Merck & Co., Inc. Precio — Gráfico — Datos Históricos
154.71
-1.73 (-1.11%)
MRK
| %Var. | Semanal | Mensual | YTD | YoY | |
|---|---|---|---|---|---|
| Merck & Co., Inc. | -1.11% | 11.48% | 14.97% | 41.56% | 76.64% |
Reciente Merck & Co., Inc. Noticias
Explainer: How the Merck/Moderna cancer vaccine works and possible barriers to wide use ↗
The personalized cancer vaccine being developed by Moderna and Merck has boosted hopes that mRNA technology could open up a new avenue of treatment…
Reuters · Aug 25, 12:32 UTC
What Happens if Moderna's Cancer Vaccine Works ↗
Moderna and Merck's personalized cancer vaccine could transform cancer treatment and create a multibillion-dollar market, but investors may already…
Barrons · Aug 25, 10:37 UTC
Nvidia Earnings and Jackson Hole Are the Stock Market's Next Big Tests ↗
Stocks are rallying, but still haven't posted meaningful gains since May. The next three days could change that.
Barrons · Aug 26, 01:00 UTC
China flexes its auto-safety chops with huge recall of Tesla, other cars ↗
A huge recall in China last week aims to address a long-standing fear of EV owners: potentially being trapped in their cars when the power fails. It…
Reuters · Aug 25, 22:42 UTC
Meta, US states have discussed settling teen social media harm case, Bloomberg News reports ↗
Meta Platforms and state attorneys general have discussed a potential mid-trial settlement of a lawsuit accusing the company of deliberately…
Reuters · Aug 25, 21:37 UTC
Intuit Says 75% of Enterprise Customers Deploy AI Agents Monthly ↗
Businesses and accountants are deploying the artificial intelligence-powered tools offered as part of Intuit Intelligence, Intuit Chairman and CEO…
PYMNTS · Aug 25, 20:47 UTC
Relacionado
| Relacionado | Precio | %Var. |
|---|---|---|
| AbbVie Inc. | 262.24 | -1.34% |
| Abbott Laboratories | 115.30 | -0.71% |
| Amgen Inc. | 441.15 | -0.25% |
| Cigna Corporation | 282.65 | 1.19% |
| Danaher Corporation | 216.30 | 0.15% |
| Elevance Health Inc. | 405.02 | 1.54% |
| Eli Lilly and Company | 1,216.7 | -1.38% |
| Gilead Sciences, Inc. | 149.00 | 0.15% |